Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
Launched by NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS (NIDCD) · Jan 3, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and researching disorders related to hearing, balance, taste, smell, voice, speech, and language. It aims to collect important clinical data and biological samples, like blood or tissue, from participants to help improve future treatments for these conditions. If you or your child are aged 2 or older and have a diagnosed or suspected issue with hearing or communication, you may be eligible to participate in this study.
As a participant, you can expect to undergo routine care and tests that are already part of your treatment. These may include hearing and balance assessments, as well as other standard health checks. All the information gathered will help researchers learn more about these disorders and potentially identify candidates for further studies. You will be supported throughout the process, and you can ask questions at any time. Participation can last up to two years, and your ongoing care will continue as needed.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- • Patients must be age 2 years or older if procedures or treatment are required.
- • Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance, taste, smell, voice, speech, language, and other ENT disorder.
- • An NIDCD clinical investigator and PI determines it is in the interest of the patient/individual and NIDCD CRP for the subject to undergo consult, treatment or follow-up at the NIDCD/NIH
- • Patient or their Legally Authorized Representative is able to provide informed consent. The consent form will be signed by parents or guardians of patients under the age of 18.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- • Candidates who do not meet the inclusion criteria.
- • Candidates who in the opinion of the PI and clinical team have medical or unstable conditions for which NIDCD and CC consultative services are unable to provide or support optimal care
About National Institute On Deafness And Other Communication Disorders (Nidcd)
The National Institute on Deafness and Other Communication Disorders (NIDCD) is a prominent agency within the National Institutes of Health (NIH) dedicated to advancing research and understanding of hearing, balance, taste, smell, voice, speech, and language disorders. Through rigorous clinical trials and innovative research initiatives, the NIDCD aims to improve the diagnosis, treatment, and prevention of communication disorders, ultimately enhancing the quality of life for individuals affected by these conditions. The institute fosters collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical practices and public health strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
Joshua M Levy, M.D.
Principal Investigator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials